India's medtech sector sets sights on tripling UK exports by 2030
- IBEF
- November 18, 2025
India’s medical devices industry is seeking a larger footprint in the United Kingdom’s (UK) Rs. 1,61,095 crore (US$ 18.17 million) medtech market, with an ambition to triple exports to Rs. 2,917-3,493 crore (US$ 329-394 million) by 2030 from Rs. 1,117 crore (US$ 126 million) in 2024. A seven-member Indian delegation recently participated in a high-level roundtable in the UK Parliament to explore opportunities under the proposed Comprehensive Economic and Trade Agreement. Discussions focused on regulatory alignment, simplified market access, manufacturing collaborations, and technology transfer. India’s current exports to the UK are dominated by consumables, disposables, and select equipment, reflecting India’s strengths in large-scale, cost-efficient production. Despite the UK accounting for around 3% of India’s total medtech exports, it remains among the top five destinations, underscoring its strategic importance.
The roundtable addressed key challenges relating to United Kingdom Conformity Assessed (UKCA) and Conformité Européenne (CE) marking requirements, expectations of the Medicines and Healthcare products Regulatory Agency, procurement norms of the National Health Service, and patient safety and sustainability standards. Industry representatives highlighted that easing regulatory pathways under strengthened bilateral trade cooperation could significantly accelerate India’s medtech penetration. The dialogue also identified opportunities for joint development of digital health and remote monitoring solutions, where India’s information Technology (IT) and health-tech expertise can support the UK’s healthcare delivery. With India targeting a position among the world’s top five medical device manufacturing hubs by 2030, stakeholders believe the export goals for the UK are both feasible and timely.
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.
Partners
